 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide 3 (GSK3787) identified potent selective ligand PPARdelta good pharmacokinetic properties. detailed binding study using mass spectral analysis confirmed covalent binding Cys249 within PPARdelta binding pocket. Gene expression studies showed pyridylsulfone 3 antagonized transcriptional activity PPARdelta inhibited basal CPT1a gene transcription. Compound 3 PPARdelta antagonist utility tool elucidate PPARdelta cell biology pharmacology.